Related Experiment Videos
Modulation of central noradrenergic function by RS-15385-197
W S Redfern1, A C MacKinnon, C M Brown
1Syntex Research Centre, Research Park, Riccarton, Edinburgh.
British Journal of Pharmacology
|February 1, 1993
Summary
RS-15385-197 is a selective alpha 2-adrenoceptor antagonist that interacts with central noradrenergic neurons. This compound is ideal for studying alpha 2-adrenoceptor roles in the central nervous system.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Alpha 2-adrenoceptors play a crucial role in regulating central noradrenergic neurotransmission.
- Selective modulators of these receptors are valuable tools for investigating their functions.
Purpose of the Study:
- To evaluate the selectivity of RS-15385-197 for central alpha 2-adrenoceptors.
- To assess its interaction with central noradrenergic neurons in vitro and in vivo.
Main Methods:
- In vitro studies using hypothalamic and cortical slices to measure neurotransmitter release and reuptuptake.
- In vivo studies in rats measuring neurochemical changes (MHPG, 5-HIAA) and receptor regulation (beta-adrenoceptors, 5-HT2 receptors).
- Behavioral tests assessing responses to clonidine and 8-OH-DPAT.
Main Results:
- RS-15385-197 demonstrated high potency and selectivity as an alpha 2-adrenoceptor antagonist in vitro.
- In vivo, it selectively increased noradrenergic transmission markers and downregulated beta-adrenoceptors, dependent on serotonergic input.
- RS-15385-197 showed selectivity for alpha 2-adrenoceptors over 5-HT1A receptors in functional tests.
Conclusions:
- RS-15385-197 exhibits high selectivity for central noradrenergic neurons.
- It is a valuable pharmacological tool for exploring the role of alpha 2-adrenoceptors in the central nervous system.